Terms of Use | Privacy Policy | HIPAA Update | Site Map   


Copyright 2007 BioSignia®, All Rights Reserved   

 

 

   

CORE TECHNOLOGY


BioSignia’s flagship technology, Synthesis Analysis, takes a multi-dimensional approach to predicting the risk of chronic disease onset, disease progression and mortality in order to effectively address the needs of diverse populations.

Synthesis Analysis is a new method for developing multivariate, predictive equations and was designed to combine results from hundreds of scientific studies worldwide. It enables predictive equations to be constantly updated to reflect the latest research findings regarding chronic disease risk factors.

As a result, professionals engaged in chronic disease prevention and management can effectively incorporate new genomic, proteomic and biochemical discoveries into existing health risk assessment (HRA) and underwriting tools. Synthesis Analysis is the “evergreen” engine that drives BioSignia’s solutions.
 

 

 

An in-depth look at Synthesis Analysis

Market applications of Know Your Number

Request expert commentary from a BioSignia scientist

Peer Reviewed Papers

View a presentation on how Synthesis Analysis works

 

 

BioSignia, Inc. • 1822 East NC Highway 54, Suite 350 • Durham, NC 27713 • (919) 933-2021 • (888) 324-6627